Ambrosia Systems, a fast growing medical technology company, announced the launch of the next version of NightRider BluCon to work with FreeStyle Libre 2 sensor. The new NightRider BluCon also works ...

The FDA has approved Abbott’s FreeStyle Libre Pro continuous glucose monitoring system for clinicians to use with diabetic patients. While Abbott markets a consumer version of the FreeStyle Libre in ...

Abbott has received FDA Clearance for its FreeStyle Libre Pro system, a key milestone in bringing the company's unique take on the continuous glucose monitor to the United States. In Europe, where the ...

Credit: Abbott. The new CGM system provides healthcare professionals with a patient's ambulatory glucose profile (AGP), showing a clearer overview of glucose levels, patterns, and trends. Abbott ...

The Food and Drug Administration recently approved the FreeStyle Libre Pro system, a continuous glucose monitoring system developed by Abbott Park, Ill.-based Abbott. To use the system, clinicians ...

MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...

Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre. Livongo Health, the digital chronic ...

- The FreeStyle Libre 3 system automatically delivers real-time, up-to-the-minute glucose readings, unsurpassed 14-day accuracy[1] and optional glucose alarms directly to smartphones[2] for people ...

The US Food and Drug Administration (FDA) has approved the FreeStyle Libre Pro System, developed by Abbott, for use by physicians for monitoring glucose in patients with diabetes. The FreeStyle Libre ...

A fingerprick isn't just a fingerprick when you have to do it all the time to test your blood sugar levels. Thankfully, the Food and Drug Administration has approved the first continuous glucose ...